Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history; older notices (v3.4.1 and a government funding banner) were removed. These updates affect the UI/site banners rather than the clinical trial content.
    Difference
    0.5%
    Check dated 2026-02-11T12:00:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A system-wide funding notice was added to the page and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page UI now includes a glossary toggle, color-coded highlights for additions and deletions, and updated revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T03:53:53.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.3.4; the entry for v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:42.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Administrative updates to the history page include a new Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2, which do not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:52:37.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision history shows a new version v3.3.2 was added and an older version v3.2.0 was removed, with no changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:45.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.